Galectin Therapeutics INC
-$8.2M
Net Activity
Institutions Holding
100
Popularity Rank
#4442
Avg Weight
0.01%
Total Value
$43.0M
Ownership Trend
100 institutions currently hold GALT, with 50 net buyers and 40 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
40
Net Buying Institutions
50
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$30.1M
Total Buy Value
$11.4M
Total Sell Value
50
Net Buyers
40
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
4
Filings (90d)
$518K
Total Est. Value
106K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Shlevin Harold H. | 2026-06-29 | $112K |
| Jamil Khurram | 2026-06-26 | $341K |
| Shlevin Harold H. | 2026-06-26 | $39K |
| Jamil Khurram | 2026-06-23 | $26K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
No Form 8-K filings for this ticker
FAQ
Who are the top institutional investors holding GALECTIN THERAPEUTICS INC (GALT)?
What is the overall institutional sentiment toward GALT recently?
Which institutions have been selling or reducing their GALT positions?
Are there any notable investors adding GALT to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter